ClawHub

Edwards Lifesciences

v1.0.0

全球心脏瓣膜和血流动力学监测领导者，TAVR技术先驱，年营收超60亿美元，心脏瓣膜市场份额全球第一。

⭐ 0· 73·0 current·0 all-time
by@hanxueyuan

Install

OpenClaw Prompt Flow

Install with OpenClaw

Best for remote or guided setup. Copy the exact prompt, then paste it into OpenClaw for hanxueyuan/edwards-lifesciences.

Previewing Install & Setup.
Prompt PreviewInstall & Setup
Install the skill "Edwards Lifesciences" (hanxueyuan/edwards-lifesciences) from ClawHub.
Skill page: https://clawhub.ai/hanxueyuan/edwards-lifesciences
Keep the work scoped to this skill only.
After install, inspect the skill metadata and help me finish setup.
Use only the metadata you can verify from ClawHub; do not invent missing requirements.
Ask before making any broader environment changes.

Command Line

CLI Commands

Use the direct CLI path if you want to install manually and keep every step visible.

OpenClaw CLI

Bare skill slug

openclaw skills install edwards-lifesciences

ClawHub CLI

Package manager switcher

npx clawhub@latest install edwards-lifesciences
Security Scan
VirusTotalVirusTotal
Benign
View report →
OpenClawOpenClaw
Benign
high confidence
✓
Purpose & Capability
The skill's name and description (company profile, history, market analysis) align with the SKILL.md content. It does not request unrelated binaries, credentials, or access that would be inconsistent with an informational/company-profile skill.
✓
Instruction Scope
SKILL.md is purely descriptive and lists contexts where the content should be read; it does not instruct the agent to access local files, environment variables, external endpoints, or perform actions beyond returning informational content.
✓
Install Mechanism
No install spec and no code files are present (instruction-only). Nothing is written to disk or downloaded during installation.
✓
Credentials
The skill requests no environment variables, credentials, or config paths — proportionate for an informational skill.
✓
Persistence & Privilege
always:false and default invocation settings are used. The skill does not request permanent presence or elevated privileges and does not modify other skills or system settings.
Assessment
This skill appears to be a safe, read-only company profile (no code, no network installs, no secrets requested). Consider that the source/homepage is unknown and content may be outdated or subjective — if you need authoritative or up-to-date data, verify facts against official Edwards Lifesciences sources (company site, filings, peer-reviewed literature). Because the skill is user-invocable and not prevented from autonomous invocation by default, check your agent's policy/settings if you want to restrict which skills can run without explicit confirmation.

Like a lobster shell, security has layers — review code before you run it.

latestvk972yy6bwz2sept6x1rczfx66185f8cg
73downloads
0stars
1versions
Updated 4d ago
v1.0.0
MIT-0
@hanxueyuan
latest
Download

Edwards Lifesciences — 守护心脏的节拍

一句话

全球心脏瓣膜治疗无可争议的领导者，Edwards Lifesciences凭借TAVR（经导管主动脉瓣置换）技术革命性地改变了心脏瓣膜疾病的治疗方式，让数百万患者免于开胸手术。

历史时间线

  • 1960：迈尔斯洛厄尔在加州创立Edward Laboratories
  • 1960年代：推出首款人工心脏瓣膜
  • 1970年代：进入血流动力学监测市场
  • 1980年代：成为心脏瓣膜修复和置换领域的领导者
  • 2000：分拆为独立上市公司（NYSE: EW）
  • 2007：开始研发TAVR技术
  • 2011：SAPIEN经导管心脏瓣膜获得FDA批准
  • 2015：SAPIEN 3获批，成为TAVR市场的领导产品
  • 2020：EVOQUE三尖瓣系统进入临床试验
  • 2024：全球TAVR市场份额超60%，年营收超60亿美元

商业模式

  • 四大业务板块：结构性心脏病（TAVR和二尖瓣/三尖瓣修复，占营收约65%）、重症监护（血流动力学监测，约20%）、外科瓣膜和修复（约10%）、其他（约5%）
  • TAVR是增长引擎：每年以15-20%的速度增长
  • 适应症扩展：从高危患者逐步扩展到低危患者，市场空间持续扩大
  • 全球培训体系：在全球设有培训中心，帮助心脏团队掌握TAVR技术

护城河分析

  • TAVR技术的临床领先地位：超过15年的临床经验和超过100万例植入的长期数据
  • 产品线完整性：从主动脉瓣到二尖瓣到三尖瓣，覆盖所有瓣膜疾病
  • 心脏团队关系：与全球数千名心外科医生和介入心脏病学家建立了深度合作关系
  • 监管壁垒：心脏瓣膜需要极其严格的临床试验和审批流程

关键数据

  • 2023年营收约64亿美元，同比增长约14%
  • TAVR全球市场份额超60%
  • SAPIEN瓣膜累计植入超50万例
  • 全球超1.5万员工
  • 研发投入约10亿美元/年（占营收约16%）

有趣事实

  • Edwards Lifesciences的创始人Jack Edwards最初是一名工程师 — 他将工程学原理应用到心脏瓣膜设计中
  • TAVR技术的核心突破是"不开胸换瓣膜" — 通过大腿动脉将瓣膜送达心脏，手术时间仅需1-2小时
  • 全球每年约有50万患者接受TAVR手术 — 这个数字预计到2030年将翻倍

Comments

Loading comments...